Alcohol Use and Relationships - III

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2012 by The University of Tennessee Knoxville
Sponsor:
Information provided by (Responsible Party):
The University of Tennessee Knoxville
ClinicalTrials.gov Identifier:
NCT01753986
First received: December 17, 2012
Last updated: December 19, 2012
Last verified: December 2012
  Purpose

The investigators hypothesize that individuals receiving the brief substance use intervention will have better substance use and intimate partner violence outcomes than individuals receiving the general health improvement intervention. All participants receive standard batterer intervention.


Condition Intervention Phase
Intimate Partner Violence
Substance Use
Behavioral: Brief Alcohol Intervention plus Standard Batterer Intervention
Behavioral: General Health Improvement Intervention plus Standard Batterer Intervention
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Impact of Brief Substance Use Intervention on Substance Use and Intimate Partner Violence

Further study details as provided by The University of Tennessee Knoxville:

Primary Outcome Measures:
  • lower levels of intimate partner violence [ Time Frame: one year ] [ Designated as safety issue: No ]
    lower levels of any violence and severe intimate partner violence (psychological, physical, sexual, injuries)


Secondary Outcome Measures:
  • lower levels of substance use (alcohol and drug) [ Time Frame: one year ] [ Designated as safety issue: No ]

Other Outcome Measures:
  • fewer arrests for violence recidivism [ Time Frame: one year ] [ Designated as safety issue: No ]

Estimated Enrollment: 500
Study Start Date: December 2012
Estimated Study Completion Date: December 2019
Estimated Primary Completion Date: December 2018 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Brief Alcohol Intervention plus Standard Batterer intervention
Brief Alcohol Intervention plus 40 hours of Standard Batterer intervention
Behavioral: Brief Alcohol Intervention plus Standard Batterer Intervention
Brief Alcohol Intervention plus 40 hours or Standard Batterer Intervention
Placebo Comparator: General Health Improvement plus Standard batterer intervention
General Health Improvement Intervention plus 40 hours of Standard Batterer intervention
Behavioral: General Health Improvement Intervention plus Standard Batterer Intervention
General Health Improvement Intervention plus 40 hours of Standard Batterer Intervention

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Participation in Batterer Intervention Program in RI
  • Hazardous Drinking

Exclusion Criteria:

  • drinks too much
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01753986

Locations
United States, Rhode Island
Butler Hospital Recruiting
Providence, Rhode Island, United States, 02906
Contact: Gregory Stuart, PhD       gstuart@utk.edu   
Sub-Investigator: Yael Schonbrun, PhD         
Sponsors and Collaborators
The University of Tennessee Knoxville
  More Information

No publications provided

Responsible Party: The University of Tennessee Knoxville
ClinicalTrials.gov Identifier: NCT01753986     History of Changes
Other Study ID Numbers: 1210-005
Study First Received: December 17, 2012
Last Updated: December 19, 2012
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Ethanol
Anti-Infective Agents
Anti-Infective Agents, Local
Central Nervous System Agents
Central Nervous System Depressants
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses

ClinicalTrials.gov processed this record on October 21, 2014